Crystallization & Isolation
Crystallization & Isolation
Crystallization & Isolation
High-Purity Isolate Production
STIX's crystallization and isolation process follows a rigorous 7-stage workflow designed to achieve laboratory-grade purity and consistent particle specifications. Every stage is conducted within a closed, controlled environment — minimizing contamination risk, maximizing solvent removal efficiency, and ensuring lot-to-lot reproducibility.
The result is an isolate product that meets stringent, documented purity specifications, with full analytical characterization and batch documentation suitable for regulatory submission.
Crystallization & Isolation
Stix operates a dedicated, GMP-aligned crystallization and isolation facility located in a fully separated wing of the building to maintain controlled material flow, environmental segregation, and compliance with pharmaceutical-oriented quality principles. All isolate production is performed using high-purity dryer filter systems manufactured by GL Filtration, including both the FD875 and FD1000 units.
Our multi-stage workflow dissolves distillate into high-purity heptane, initiates controlled crystal growth in jacketed crystallization reactors, then washes, dries, centrifuges, and finishes the isolate in Cascade Sciences vacuum ovens before milling, sieving, and final QC testing — ensuring consistent particle size and batch uniformity with minimal handling.
Every stage is tracked through Stix’s custom-built track and trace software, recording material movement, batch parameters, yield performance, equipment utilization, and process deviations. This integrated platform enables high-purity, laboratory-grade cannabinoid isolates with exceptional consistency.